-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614.O1.6 614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies I

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Non-Biological therapies, Workforce, Diseases, Therapies, Lymphoid Malignancies
Sunday, December 12, 2021: 9:30 AM-11:00 AM
B211-B212, Level 2, Building B (Georgia World Congress Center)
Moderators:
Shira Dinner, MD, Northwestern University and Jennifer L. McNeer, MD, University of Chicago
Disclosures:
McNeer: Jazz Pharmaceuticals: Other: Advisory Board Member.
9:30 AM

Inge M. Van Der Sluis, MD, PhD1,2, Paola De Lorenzo, PhD3*, Rishi Sury Kotecha, PhD, FRACP, MBBChir, MRCP4,5*, Andishe Attarbaschi, MD6*, Gabriele Escherich, MD7,8*, Karsten Nysom, MD, PhD9*, Jan Stary, Prof., MD, PhD10,11*, Alina Ferster, MD12, Benoit Brethon, MD13*, Phillip Ancliff14*, Andrea Biondi, MD15, Maria Grazia Valsecchi, PhD16* and Rob Pieters, Prof, MD, PhD1,2

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Dutch Childhood Oncology Group, Utrecht, Netherlands
3Bicocca Bioinformatics, Biostatistics and Bioimaging Centre, Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy
4Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, Australia
5ANZCHOG - Australian and New Zealand Children's Haematology/Oncology Group, Perth, Australia
6Department of Pediatric Hematology and Oncology, St. Anna Children’s Hospital, Medical University of Vienna, Vienna, Austria
7Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany
8COALL - German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany
9Rigshospitalet, Copenhagen, Denmark
10CPH- Czech Working Group for Pediatric Hematology, Prague, Czech Republic
11Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic
12Pediatric Hemato-Oncology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium
13Department of Pediatric Hematology and Immunology, Robert-Debré Hospital, AP-HP, University of Paris, Paris, France
14Great Ormond Street Hospital, London, United Kingdom
15Tettamanti Research Center, Department of Pediatrics, University of Milano - Bicocca/Fondazione MBBM, Monza, MI, Italy
16Bicocca Bioinformatics, Biostatistics and Bioimaging Centre B4, Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy

9:45 AM

Nicola Goekbuget, MD1, Matthias Stelljes, MD2, Andreas Viardot, MD3, Kathrin Nachtkamp, MD4*, Björn Steffen, MD5*, Folker Schneller, MD6*, Nael Alakel, MD7*, Max Topp8, Boris Böll, MD9*, Christoph Faul, MD10, Karsten Spiekermann, MD11, Knut Wendelin, MD12*, Maher Hanoun, MD, PhD13*, Ralph Wäsch14, Joachim Beck, MD15*, Sonja Martin, MD16*, Vladan Vucinic, MD17*, Claudia D. Baldus, MD18*, Monika Brüggemann, Prof., PhD19*, Thomas Burmeister, MD20*, Heike Pfeifer, MD21*, Stefan Schwartz, MD22*, Lena Baumann5*, Diana Tichy, PhD23*, Hubert Serve, MD5 and Walter Fiedler, MD24

1Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt, Germany
2Department of Medicine A, Hematology, Oncology and Pneumology, University of Muenster, Muenster, Germany
3Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
4Dept. of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
5Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany
6Medical Department III, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
7University of Dresden, Dresden, DEU
8Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
9Hematology/Oncology, University Hospital Cologne, Cologne, NRW, Germany
10Internal Medicine II, University Hospital and Comprehensive Cancer Center Tübingen, Universitätsklinikum Tübingen, Tübingen, Germany
11Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
12Klinikum Nuernberg, Paracelsus Medizinische Privatuniversität, Nuernberg, Germany
13Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
14Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
15Universitatsmedizin Mainz, Mainz, Schkeuditz, Germany
16Department of Hematology and Oncology, Robert-Bosch-Hospital, Stuttgart, Germany
17Clinic and Policlinic for Hematology and Cellular Therapy, University of Leipzig Medical Center, Leipzig, Germany
18Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
19Medical Department II, Laboratory of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
20Department of Hematology / Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany
21Klinikum der Goethe University, Department of Hematology, Frankfurt am Main, DEU
22Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
23Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany
24Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Hospital Eppendorf, Hamburg, Germany

10:00 AM

Patrick A. Brown, MD1, Lingyun Ji2*, Xinxin Xu3*, Meenakshi Devidas, PhD4*, Laura Hogan, MD5, Teena Bhatla6*, Michael Borowitz, MD, PhD7, Elizabeth A. Raetz, MD8, Lia Gore, MD9, James A. Whitlock, MD10, Stephen P. Hunger, MD11 and Mignon L. Loh, MD12

1Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
2Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles
3Children's Oncology Group, Monrovia, CA
4Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN
5Stony Brook Children's, Stony Brook, NY
6Children's Hospital of New Jersey at Newark Beth Israel, Newark, NJ
7Departments of Pathology and Oncology, Johns Hopkins Hospital, Baltimore, MD
8Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY
9Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado and Children’s Hospital, Aurora, CO
10Division of Haematology/Oncology, The Hospital For Sick Children, Toronto, ON, Canada
11Department of Pediatrics, Division of Oncology and the Center for Childhood Cancer Research, CHILDREN'S HOSPITAL OF PHILADELPHIA, Philadelphia, PA
12Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California Benioff Children’s Hospital, San Francisco, CA

10:15 AM

Sujith Samarasinghe1*, Ajay Vora2, Nicholas John Goulden, MD, PhD, MRCPath3*, Grace Antony4* and Anthony V. Moorman, PhD5

1Great Ormond Street Hospital, London, United Kingdom
2Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
3Great Ormond Street Hospital, London, GBR
4Newcastle University, Newcastle upon Tyne, United Kingdom
5Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom

10:30 AM

Eleni Argyriadi, MD1*, Ingo G. Steffen, MD1*, Guenter Henze, MD, PhD1*, Christiane Chen-Santel, MD1,2* and Arend von Stackelberg, MD1

1Department of Pediatric Oncology/Hematology, Charite Medical Center, Berlin, Germany
2Department of Pediatrics, University Medical Centre, Rostock, Rostock, Germany

10:45 AM

Clare J Rowntree1*, Amy A Kirkwood, MSc2*, Laura Clifton-Hadley, PhD3*, Nadine Farah, MBBChir, PhD4*, Marc R. Mansour, MD PhD FRCPath5*, Jiaull Hussain6*, David I. Marks, MB, PhD7, Andrew K. McMillan, MBBS, PhD8*, Tobias F. Menne, MD, PhD9*, Anthony V. Moorman, PhD10, Pip Patrick, PhD, MSc, MA6*, Bela Wrench, MBBS, MD11* and Adele K. Fielding, MBBS, PhD4

1Department of Haematology, University Hospital of Wales, Cardiff, United Kingdom
2Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom
3Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom
4Department of Haematology, UCL Cancer Institute, London, United Kingdom
5Cancer Institute, University College London, London, United Kingdom
6Cancer Research UK and University College London Cancer Trials Centre, London, United Kingdom
7Haematology and Stem Cell Transplantation, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
8Nottingham University Hospital NHS Trust, Nottingham, United Kingdom
9Freeman Hospital/Newcastle University, Newcastle-Upon-Tyne, United Kingdom
10Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
11Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

*signifies non-member of ASH